Genexine (095700.KQ) Earnings Analysis

Genexine (095700.KQ) next reports earnings on 2026-08-18, consensus EPS 157.81 KRW. Last quarter (2026-02-02) it missed with EPS -317.55 KRW vs 157.81 KRW est (-301.2%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -5.38.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 095700.KQ next report earnings?

Next earnings date2026-08-18
Consensus EPS estimate157.81 KRW
Revenue estimate0.41B

095700.KQ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-02-317.55 KRW157.81 KRW-301.2%Miss
2025-05-14-416.0947 KRWn/an/an/a
2025-02-05-589.44665 KRWn/an/an/a
2024-11-14-350.99999 KRWn/an/an/a

Beat rate: 0/1 (0%) over reported quarters with consensus data.

095700.KQ valuation and analyst view

Trailing P/E-5.38
Trailing EPS-451.48105 KRW
Price / book0.48
Dividend yield0.00%
Market cap106.42B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Genexine (095700.KQ)'s next earnings date?

Genexine is next scheduled to report on 2026-08-18, with a consensus EPS estimate of 157.81 KRW and revenue estimate of 0.41B.

Did 095700.KQ beat earnings last quarter?

In its 2026-02-02 report, 095700.KQ posted EPS of -317.55 KRW versus a 157.81 KRW estimate — a miss of 301.2%.

What is 095700.KQ's earnings track record?

Over the last 1 reported quarters with consensus data, 095700.KQ beat estimates 0 times (0%).

What is 095700.KQ's current P/E ratio and EPS?

095700.KQ trades at a trailing P/E of -5.38 on trailing EPS of -451.48104661389624 KRW.

What do analysts rate 095700.KQ?

095700.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.